IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in target tissue: A possible role for nitric oxide

Journal of Immunology

Volumn 163, Issue 10, 1999, Pages 5278-5286

  Willenborg, David O ^a,b   Fordham, Susan A ^a   Staykova, Maria A ^a   Ramshaw, Ian A ^c   Cowden, William B ^c  

^a CANBERRA HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ASCITIC FLUID; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SPECIFICITY; RADIATION CHIMERA; RECEPTORS, INTERFERON; SPLEEN;

EID: 0033571331     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Raine, C. S., L. B. Barnett, A. Brown, and D. E. McFarlin. 1980. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:150.
2. Ludowyk, P. A., W. Hughes, A. Hugh, D. O. Willenborg, K. A. Rockett, and C. R. Parish. 1993. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalomyelitis in aged rats. J. Neuroimmunol. 48:121.
3. Lafaille, J. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myein Basic protein-specific T helper 2 (TH2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
4. Baron, J. L., J. A. Madri, N. H. Ruddle, G. Hashim, and C. A. Janeway. 1993. Surface expression of α4 inlegrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57.
5. Ando, D. G., J. Clayton, D. Kono, J. L. Urban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine type. Cell. Immunol. 124:132.
6. Zamvil, S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579.
7. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245.
8. Willenborg, D. O., S. A. Fordham, C. C. A. Bernard, W. B. Cowden, and I. A. Ramshaw. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223.
9. Huang, S., Hendriks, W., Althage, A., Bluethman, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M., and Auget, M. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
10. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterisation of B-cell stimulatory factor-1. Nature 315:333.
11. G- mono-, di-, and trimethylated arginines. Acta Biochem. Biophys. Acad. Sci. Hungaricae 12:191.
12. Rockett, K. A., M. M. Awburn, E. J. Rockett, W. B. Cowden and Clark, I. A. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:243.
13. Farrer, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571.
14. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171.
15. + suppressor T cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 22:1757.
16. Chen, Y., V. K. Kuchroo, J. I. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cells clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
17. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80:707.
18. Palmer, R., A. G. Ferriage, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of EDRF. Nature 327:524.
19. Bredt, D. S., and S. H. Snyder. 1994. Nitric oxide synthase structure and mechanism. Annu. Rev. Biochem. 63:175.
20. Gillespie, J. S., X. Liu, and W. Martin. 1989. The effect of L-arginine and N-methyl-L-arginine on the response of the rat anoccoccygeus to NANC nerve stimulation. Br. J. Pharmacol. 98:1080.
21. Hibbs, J. B., R. R. Taintor, Z. Vavrin, and E. M. Rachlin, 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87.
22. Nathan, C. F., and J. B. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
23. Böhme, A. G., C. Bon, M. Lemaire, M. Reibaud, O. Piot, J.-M. Stutzman, A. Doble, and J.-C. Blanchard. 1993. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor treated rats. Proc. Natl. Acad. Sci. USA 90:9191.
24. Zhuo, M. S., S. A. Small, E. R. Kandel, and R. D. Hawkins. 1993. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science 260:1946.
25. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthase: roles, tolls and control. Cell 78:919.
26. Vladutiu, A. O. 1995. Role of nitric oxide in autoimmunity. Clin. Immunol. Immunopathol. 76:1.
27. Hooper, D. C., O. Bagasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobrowski, J. L. Farber, et al. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:2528.
28. Huang, F. P., G. J. Feng, G. Lindop, D. I. Stott, and F. Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous disease in MRL:MP-lpr:lpr mice. J. Exp. Med. 183:1447.
29. McCartney-Francis, N., J. B. Allen, D. E. Mizel, J. E. Albina, Q.-W. Xie, C. F. Nathan, and S. M. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749.
30. Fuseler, J. W., E. M. Conner, J. M. Davis, R. E. Wolf, and M. B. Grisham. 1997. Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis. Inflammation 21:113.
31. Corbett, J. A., A. Mikhael, J. Shimizu, K. Fredrick, T. P. Misko, M. L. McDaniel, O. Kanawaga, and E. R. Unanue. 1993. Nitric oxide production in islets from nonobese diabetic mice: aminoguanine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA 90:8992.
32. Lin, R. F., T. S. Lin, R. G. Tilton, and A. H. Cross. 1993. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramegnetic resonance study. J. Exp. Med. 178:643.
33. Zhao, W. G., R. G. Tilton, J. A. Corbett, M. L. McDaniel, T. P. Misko, J. R. Williamson, A. H. Cross, and W. F. Hickey. 1996. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:123.
34. Brenner, T., S. Brocke, F. Szafer, R. A. Sobel, J. F. Parkinson., D. H. Perez, and L. Steinman. 1997. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:2940.
35. Wei, X., I. G. Charles, A. Smith, J. Ure, G. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
36. Zielasek, J., S. Jung, R. Gold, F. Y. Liew, K. V. Toyka, and H. P. Hartung. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:81.
37. Ruuls, S. R., S. Vanderlinden, K. Sontrop, I., Huitinga, and C. D. Dijkstra. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) sythases inhibitors. Clin. Exp. Immunol. 103:467.
38. Cowden, W. B., F. A. Cullen, M. A. Staykova, and D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1.
39. Sun, D., C. Coleclough, L. Cao, X. Hu, S. Sun, and J. N. Whitaker. 1998. Reciprocal stimulation between TNF-α and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 89:122.
40. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse periotoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
41. Mills, C. D. 1991. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthase pathway. J. Immunol. 146:2719.
42. Duhe, R. J., G. A. Evans, R. A. Erwin, R. A. Kirken, G. W. Cox, and W. L. Farrer, 1998. Nitric oxide and thiol redox regulation of Janus kinase activity. Proc. Natl. Acad. Sci. USA 95:126.
43. Ihle, J. N. 1994. The Janus kinase family and signaling through members of the cytokine receptor superfamily. Proc. Soc. Exp. Biol. Med. 206:268.
44. Taylor-Robinson, A. W. 1997. Inhibition of IL-2 production by nitric oxide: a novel self-regulatory mechanism for Th1 cell proliferation. Immunol. Cell Biol. 75:167.
45. Mattner, F., S. Fischer, S. Guckes, S. Jin, H. Kaulen, E. Schmitt, E. Rude, and T. Germann. 1993. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:2202.
46. Nicotera, P., B. Brune, and G. Bagetta. 1997. Nitric oxide: inducer or suppressor of apoptosis. Trends Pharmacol. Sci. 18:189.
47. Pender, M. P., K. B. Nguyen, P. A. McCombe, and J. F. R. Kerr. 1991. Apoptosis in the central nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104:81.
48. Nguyen, K. B., P. A. McCombe, and M. P. Pender. 1994. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Autoimmun. 7:145.
49. Okuda, Y., S., Sakoda, H. Fujimura, and T. Yanagihara. 1997. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:107.
50. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal death in T helper cell Th1 and Th2 effectors: Th1 but not Th2, effectors undergo rapid Fas/Fas ligand-mediated apoptosis. J. Exp. Med. 185:1837.
51. Horwitz, M. S., C. F. Evans, D. B. McGavern, M. Rodriguez and M. B. Oldstone. 1997. Primary demyelination in transgenic mice expressing interferon-γ. Nat. Med. 3:1037.